Debate: Molecular Therapies in Pancreatic Ductal Adenocarcinoma: NGS for All or None - DISCUSSION

Panelist(s)

• 

  Philip A. Philip, MD, PhD, FRCP

  Wayne State University School of Medicine/Henry Ford Health
  Detroit, United States
• 

  Thierry Conroy, MD

  institut de cancérologie de Lorraine
  Vandoeuvre-les-Nancy, France